Blonder Tongue Laboratories (BDRL)
OTHER OTC:BDRL
US Market
Holding BDRL?
Track your performance easily

Blonder Tongue Laboratories (BDRL) Stock Price & Analysis

203 Followers

BDRL Stock Chart & Stats


Financials

Annual

Ownership Overview

61.89%0.00%2.46%35.65%
61.89%
Insiders
2.46% Other Institutional Investors
35.65% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

BDRL FAQ

What was Blonder Tongue Laboratories’s price range in the past 12 months?
Blonder Tongue Laboratories lowest stock price was $0.06 and its highest was $0.27 in the past 12 months.
    What is Blonder Tongue Laboratories’s market cap?
    Currently, no data Available
    When is Blonder Tongue Laboratories’s upcoming earnings report date?
    Blonder Tongue Laboratories’s upcoming earnings report date is Nov 15, 2023 which is 317 days ago.
      How were Blonder Tongue Laboratories’s earnings last quarter?
      Blonder Tongue Laboratories released its earnings results on Aug 14, 2023. The company reported -$0.052 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.052.
        Is Blonder Tongue Laboratories overvalued?
        According to Wall Street analysts Blonder Tongue Laboratories’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Blonder Tongue Laboratories pay dividends?
          Blonder Tongue Laboratories does not currently pay dividends.
          What is Blonder Tongue Laboratories’s EPS estimate?
          Blonder Tongue Laboratories’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Blonder Tongue Laboratories have?
          Blonder Tongue Laboratories has 13,368,538 shares outstanding.
            What happened to Blonder Tongue Laboratories’s price movement after its last earnings report?
            Blonder Tongue Laboratories reported an EPS of -$0.052 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -31.25%.
              Which hedge fund is a major shareholder of Blonder Tongue Laboratories?
              Currently, no hedge funds are holding shares in BDRL
              ---

              Blonder Tongue Laboratories Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -46.00%
              12-Months-Change

              Fundamentals

              Return on Equity
              Trailing 12-Months
              Asset Growth
              -14.41%
              Trailing 12-Months

              Company Description

              Blonder Tongue Laboratories

              Blonder Tongue Laboratories, Inc. operates as a technology development and manufacturing company, which engages in delivering television signal encoding, transcoding, digital transport, and broadband product solutions for applications. It also offers system operators and integrators serving the cable, broadcast, satellite, institutional, and professional video markets with solutions for the provision of content contribution, distribution, and video delivery to homes and businesses. The company was founded by Ben H. Tongue and Isaac S. Blonder in 1950 and is headquartered in Old Bridge, NJ.
              ---

              BDRL Earnings Call

              Q3 2022
              0:00 / 0:00
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Comtech Telecommunications
              Clearfield
              CommScope Holding
              Infinera
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis